statistiche ricercatore

DENTALI, FRANCESCO

Distribuzione geografica

Continente	#
NA - Nord America	38.478
EU - Europa	16.607
AS - Asia	12.532
SA - Sud America	1.531
Continente sconosciuto - Info sul continente non disponibili	596
AF - Africa	238
OC - Oceania	18
Totale	70.000

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	37.801
IT - Italia	7.765
SG - Singapore	4.069
CN - Cina	2.645
UA - Ucraina	2.307
TR - Turchia	1.666
VN - Vietnam	1.601
HK - Hong Kong	1.453
SE - Svezia	1.242
BR - Brasile	1.240
DE - Germania	1.225
IE - Irlanda	812
GB - Regno Unito	783
FI - Finlandia	724
FR - Francia	684
RU - Federazione Russa	510
BD - Bangladesh	342
CA - Canada	322
IN - India	229
MX - Messico	161
NL - Olanda	109
JP - Giappone	101
AR - Argentina	94
ES - Italia	88
PL - Polonia	75
IQ - Iraq	66
ZA - Sudafrica	66
AT - Austria	62
NG - Nigeria	43
PK - Pakistan	42
EC - Ecuador	40
CO - Colombia	38
LT - Lituania	38
BE - Belgio	36
ID - Indonesia	35
CL - Cile	30
VE - Venezuela	30
EU - Europa	29
JM - Giamaica	28
MA - Marocco	28
SA - Arabia Saudita	28
CR - Costa Rica	27
PH - Filippine	27
MY - Malesia	26
UZ - Uzbekistan	26
GT - Guatemala	25
HN - Honduras	24
IL - Israele	24
CZ - Repubblica Ceca	22
KE - Kenya	21
SV - El Salvador	21
AE - Emirati Arabi Uniti	19
PY - Paraguay	19
JO - Giordania	18
NP - Nepal	18
AU - Australia	17
TT - Trinidad e Tobago	17
EG - Egitto	15
MD - Moldavia	15
PT - Portogallo	15
NI - Nicaragua	14
RO - Romania	14
BO - Bolivia	13
GR - Grecia	13
PE - Perù	13
TN - Tunisia	13
UY - Uruguay	13
CH - Svizzera	12
TH - Thailandia	12
EE - Estonia	11
IR - Iran	11
AZ - Azerbaigian	10
DZ - Algeria	10
KR - Corea	10
AL - Albania	8
ET - Etiopia	8
SN - Senegal	8
TW - Taiwan	8
BB - Barbados	7
CI - Costa d'Avorio	7
LB - Libano	7
DO - Repubblica Dominicana	6
HU - Ungheria	6
KZ - Kazakistan	6
OM - Oman	6
PR - Porto Rico	6
RS - Serbia	6
SC - Seychelles	5
AO - Angola	4
BA - Bosnia-Erzegovina	4
CW - ???statistics.table.value.countryCode.CW???	4
DK - Danimarca	4
KW - Kuwait	4
MK - Macedonia	4
NO - Norvegia	4
XK - ???statistics.table.value.countryCode.XK???	4
A2 - ???statistics.table.value.countryCode.A2???	3
AM - Armenia	3
BS - Bahamas	3
GE - Georgia	3
Totale	69.390

Salva come PNG Salva come JPEG

Città	#
Milan	5.100
Fairfield	4.111
Ashburn	3.385
San Jose	3.260
Woodbridge	2.671
Singapore	2.225
Houston	1.964
Jacksonville	1.811
Seattle	1.624
Wilmington	1.507
Hong Kong	1.435
Chandler	1.387
Cambridge	1.386
Ann Arbor	1.312
Council Bluffs	1.279
Dallas	930
Izmir	816
Dublin	804
Princeton	790
The Dalles	674
Dearborn	591
Beijing	550
Nyköping	539
Boardman	504
Lauterbourg	421
Rome	389
Chicago	377
Dong Ket	367
Los Angeles	328
New York	323
Ho Chi Minh City	315
Munich	301
Santa Clara	274
San Diego	256
Helsinki	203
London	200
Hanoi	197
San Mateo	159
São Paulo	159
Ogden	153
Como	127
Orem	125
Washington	125
Guangzhou	108
Mexico City	101
Phoenix	100
Buffalo	93
Montreal	85
Tokyo	83
Atlanta	82
Nuremberg	81
Brooklyn	78
Frankfurt am Main	75
Düsseldorf	71
North Bergen	71
Toronto	69
Chennai	68
Denver	65
Hefei	65
Shanghai	65
Redmond	64
Naples	63
Verona	61
Nanjing	60
Warsaw	59
San Francisco	58
Norwalk	56
Kunming	55
Salt Lake City	55
Turku	55
Tianjin	53
Hangzhou	51
Manchester	49
Paris	45
Shenzhen	45
Haiphong	44
Philadelphia	44
Boston	43
Stockholm	42
Amsterdam	41
Abuja	40
Columbus	40
Johannesburg	39
Kocaeli	39
Rio de Janeiro	38
Varese	38
Belo Horizonte	34
Catania	34
Elk Grove Village	34
Jinan	34
Da Nang	31
Poplar	31
Tampa	31
Brussels	30
Kilburn	30
Mumbai	30
Las Vegas	27
Miami	27
Nanchang	27
Zhengzhou	27
Totale	48.518

Salva come PNG Salva come JPEG

Nome	#
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	428
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature	386
Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?	333
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	328
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery	321
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study	316
Warfarin interactions with antibiotics in the ambulatory care setting	302
Optimal treatment duration of venous thrombosis	282
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature	282
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	279
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19	271
ABO blood group and vascular disease: an update	270
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism	269
Risk of recurrence of unusual site venous thromboembolism	267
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	266
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature	263
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment	255
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal	251
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	250
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.	246
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.	246
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis	244
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study	241
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	239
Venous ischemic syndromes	239
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome	238
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism	238
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	237
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice	237
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis.	234
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy	232
Patient selection for thromboprophylaxis in medical inpatients	229
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	228
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study	226
Venous and arterial thrombosis in patients with HIV infection	226
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature	226
Abdominal obesity and the risk of recurrent deep vein thrombosis.	225
Statins, fibrates, and venous thromboembolism: a meta-analysis.	224
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis	224
Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence	224
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	223
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	222
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature	222
Duration of anticoagulation after venous thromboembolism in real world clinical practice	221
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	220
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature	217
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes	216
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	216
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study	215
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	215
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism.	213
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens	211
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation	209
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy	209
Seasonal and monthly variation in occurrence of hypertensive urgency	208
5 flourouracil-induced apical ballooning syndrome: a case report.	207
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage	206
Statins for acute ischemic stroke	206
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis	206
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding	206
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians	205
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.	205
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	204
Statins and secondary prevention of ischemic and hemorrhagic stroke	203
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal	203
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience	203
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding	202
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening	202
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature	202
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases	201
Abdominal pain as pulmonary embolism presentation, usefulness of bedside ultrasound: A report of two cases	201
Italian intersociety consensus on DOAC use in internal medicine	201
In vitro effects of Apixaban on 5 different cancer cell lines	201
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	201
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.	201
A CLINICAL ASSESSMENT MODEL TO SELECT ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION FOR A SAFE WARFARIN TREATMENT	200
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.	200
Neutrophil-to-lymphocyte ratio: A new prognostic factor even in patients with heart failure	200
sRAGE and early signs of cardiac target organ damage in mild hypertensives	200
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	199
Is diabetes a hypercoagulable state? A critical appraisal	199
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study	198
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	197
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy	197
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation	196
Should the commonly accepted definition of "unprovoked venous thrombembolism" be revisited?	195
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study	195
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events	195
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	195
General practitioner–performed compression ultrasonography for diagnosis of deep vein thrombosis of the leg: A multicenter, prospective cohort study	195
Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: A systematic review and meta-analysis	195
How I treat splanchnic vein thrombosis	194
Combined aspirin-oral anticoagulanttherapy compared with oral anticoagulant therapy alone among patients at risk forcardiovascular disease: a meta-analysis of randomized trials.	194
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	194
The role of thrombolytic therapy in pulmonary embolism	193
Low-molecular -weight heparin in pregnancies after ART -A retrospective study-	193
External validation of the DASH prediction rule: a retrospective cohort study	193
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.	192
Prevention of in-hospital VTE: why can't we do better?	191
Retrievable vena cava filters: a clinical review.	191
Totale	22.716

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	307.740
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	307.740

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	2.899	0	0	0	104	219	172	325	215	229	726	411	498
2022/2023	4.390	480	206	318	379	303	956	14	576	652	244	140	122
2023/2024	8.221	1.245	1.282	1.286	1.563	1.639	574	66	119	241	95	43	68
2024/2025	6.800	46	52	1.123	178	236	465	373	543	743	705	584	1.752
2025/2026	16.659	1.049	1.000	917	1.983	1.355	881	3.629	1.101	2.024	1.139	948	633
2026/2027	5.536	495	1.167	2.139	1.735	0	0	0	0	0	0	0	0
Totale													70.000